Osaic Holdings’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.9K | Buy |
507
+171
| +51% | +$23.6K | ﹤0.01% | 4431 |
|
|
2025
Q1 | $52.4K | Sell |
336
-1,568
| -82% | -$244K | ﹤0.01% | 4664 |
|
|
2024
Q4 | $262K | Buy |
1,904
+1,131
| +146% | +$156K | ﹤0.01% | 3356 |
|
|
2024
Q3 | $115K | Buy |
773
+394
| +104% | +$58.8K | ﹤0.01% | 4116 |
|
|
2024
Q2 | $51.7K | Sell |
379
-11,946
| -97% | -$1.63M | ﹤0.01% | 4632 |
|
|
2024
Q1 | $1.86M | Buy |
12,325
+11,456
| +1,318% | +$1.73M | ﹤0.01% | 1750 |
|
|
2023
Q4 | $109K | Sell |
869
-293
| -25% | -$36.9K | ﹤0.01% | 4373 |
|
|
2023
Q3 | $109K | Sell |
1,162
-122
| -10% | -$11.4K | ﹤0.01% | 4438 |
|
|
2023
Q2 | $115K | Buy |
1,284
+267
| +26% | +$23.8K | ﹤0.01% | 4331 |
|
|
2023
Q1 | $109K | Buy |
1,017
+155
| +18% | +$16.6K | ﹤0.01% | 4374 |
|
|
2022
Q4 | $105K | Sell |
862
-87
| -9% | -$10.6K | ﹤0.01% | 4391 |
|
|
2022
Q3 | $99K | Buy |
949
+78
| +9% | +$8.14K | ﹤0.01% | 4379 |
|
|
2022
Q2 | $81K | Buy |
871
+220
| +34% | +$20.5K | ﹤0.01% | 4576 |
|
|
2022
Q1 | $76K | Sell |
651
-25
| -4% | -$2.92K | ﹤0.01% | 4778 |
|
|
2021
Q4 | $91K | Sell |
676
-1,304
| -66% | -$176K | ﹤0.01% | 4658 |
|
|
2021
Q3 | $315K | Sell |
1,980
-115
| -5% | -$18.3K | ﹤0.01% | 3499 |
|
|
2021
Q2 | $275K | Sell |
2,095
-17
| -0.8% | -$2.23K | ﹤0.01% | 3595 |
|
|
2021
Q1 | $272K | Buy |
2,112
+271
| +15% | +$34.9K | ﹤0.01% | 3465 |
|
|
2020
Q4 | $308K | Buy |
1,841
+112
| +6% | +$18.7K | ﹤0.01% | 3096 |
|
|
2020
Q3 | $266K | Buy |
1,729
+324
| +23% | +$49.8K | ﹤0.01% | 2985 |
|
|
2020
Q2 | $207K | Buy |
1,405
+1,302
| +1,264% | +$192K | ﹤0.01% | 3107 |
|
|
2020
Q1 | $11K | Buy |
+103
| New | +$11K | ﹤0.01% | 4891 |
|